1. Home
  2. VIR vs NX Comparison

VIR vs NX Comparison

Compare VIR & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • NX
  • Stock Information
  • Founded
  • VIR 2016
  • NX 1927
  • Country
  • VIR United States
  • NX United States
  • Employees
  • VIR N/A
  • NX N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • NX Metal Fabrications
  • Sector
  • VIR Health Care
  • NX Industrials
  • Exchange
  • VIR Nasdaq
  • NX Nasdaq
  • Market Cap
  • VIR 724.1M
  • NX 824.7M
  • IPO Year
  • VIR 2019
  • NX N/A
  • Fundamental
  • Price
  • VIR $5.57
  • NX $17.26
  • Analyst Decision
  • VIR Buy
  • NX Strong Buy
  • Analyst Count
  • VIR 6
  • NX 1
  • Target Price
  • VIR $35.67
  • NX $38.00
  • AVG Volume (30 Days)
  • VIR 1.4M
  • NX 525.3K
  • Earning Date
  • VIR 05-01-2025
  • NX 06-05-2025
  • Dividend Yield
  • VIR N/A
  • NX 1.87%
  • EPS Growth
  • VIR N/A
  • NX N/A
  • EPS
  • VIR N/A
  • NX 0.29
  • Revenue
  • VIR $74,205,000.00
  • NX $1,438,751,000.00
  • Revenue This Year
  • VIR N/A
  • NX $48.92
  • Revenue Next Year
  • VIR $17.69
  • NX $3.10
  • P/E Ratio
  • VIR N/A
  • NX $59.01
  • Revenue Growth
  • VIR N/A
  • NX 29.87
  • 52 Week Low
  • VIR $4.95
  • NX $15.53
  • 52 Week High
  • VIR $14.45
  • NX $36.30
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.32
  • NX 41.47
  • Support Level
  • VIR $4.95
  • NX $16.65
  • Resistance Level
  • VIR $6.02
  • NX $18.68
  • Average True Range (ATR)
  • VIR 0.48
  • NX 1.20
  • MACD
  • VIR -0.00
  • NX -0.06
  • Stochastic Oscillator
  • VIR 29.25
  • NX 37.20

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: